Influenza virus vaccine 2024-2025 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe
RxNorm 2675669
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2675669 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2024-2025 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
0.5 mL influenza A virus A/California/122/2022 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML Prefilled Syringe
(Atom ID: 12875653)
SYPrescribable
Synonym (SY):
Influenza virus vaccine 2024 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe, southern hemisphere
(Atom ID: 12875660)
PSNPrescribable
Prescribable Name (PSN):
Influenza virus vaccine 2024-2025 (quadrivalent - California/Victoria/Michigan/Phuket) 0.5 mL Prefilled Syringe
(Atom ID: 12900415)
SYPrescribable